This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Yuhan Corporation. Active years: 2009-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2026
Title: Innovations by Hyun-Ho Choi: A Focus on Pyrrolo[3,2-c]pyridine Derivatives
Introduction
Hyun-Ho Choi, an innovative inventor based in Seoul, South Korea, has made significant contributions to the field of pharmaceuticals. With his extensive research and creativity, he holds a patent that reflects his commitment to enhancing medical treatments.
Latest Patents
Hyun-Ho Choi's notable patent is focused on Pyrrolo[3,2-c]pyridine derivatives and their preparation processes. This patent presents novel pyrrolo[3,2-c]pyridine derivatives and pharmaceutically acceptable salts that exhibit excellent proton pump inhibition effects. Moreover, these compounds have the capability to achieve a reversible proton pump inhibitory effect, making them promising candidates for further pharmaceutical development.
Career Highlights
Hyun-Ho Choi is associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His dedication to research and innovation at Yuhan Corporation has positioned him as a key player in the development of new therapeutic agents. His intellectual contributions have paved the way for advancements in medical science.
Collaborations
Throughout his career, Hyun-Ho Choi has collaborated with talented professionals such as Jae-Gyu Kim and Byung-Nak Ahn. These partnerships have fostered an environment of innovation and shared knowledge, enhancing the research and development processes in their field.
Conclusion
Hyun-Ho Choi's work exemplifies the essence of innovation in the pharmaceutical industry. His patent on Pyrrolo[3,2-c]pyridine derivatives not only showcases his inventive capabilities but also contributes to the ongoing pursuit of effective medical treatments. As he continues his research at Yuhan Corporation, the potential for further groundbreaking advancements remains high.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
